Section Ph 1105.01 - Collaborative Practice Agreements(a) Collaborative practice agreements shall describe in detail services that a pharmacist may perform for a patient, including but not limited to: (1) Specific drugs to be managed by the pharmacist;(2) Terms and conditions under which a drug therapy may be implemented, modified, or discontinued;(3) Conditions and events upon which the pharmacist is required to notify the collaborating practitioner, and the manner and time frame in which such notification shall occur;(4) The laboratory tests that may be ordered to manage a medication therapy;(5) Activities which may be performed by the pharmacist in conjunction with a written protocol;(6) A statement of the expected amount of dedicated time that a pharmacist will use exclusively to perform duties in the collaborative agreement;(7) Documentation of the care delivered and, if applicable, methods of communication of essential information the patient's other health care providers;(8) Education and training designed to enhance patient understanding and the appropriate use of his or her medication;(9) The beginning and ending dates of the period of time during which the agreement is in effect;(10) A statement that the agreement may be terminated in writing by either party at any time, subject to (c) below; and(11) A description of the private, HIPAA-compliant space to be utilized for collaborative practice.(b) Collaborative agreements shall be renewed at least every 2 years and signed by all practitioners who are a party to the agreement.(c) When a collaborative agreement between the pharmacist and the practitioner is terminated, the pharmacist shall provide notification to the patient and document in the electronic medical record. Such notification shall include detailed information on how the patient may continue any medication therapy provided by the pharmacist without interruption.(d) Collaborative practice agreements shall include quality metrics developed by pharmacist(s) and practitioners.(e) Pharmacists shall keep a copy of each collaborative agreement, including any protocols specified in such agreements, to which they are a party at their place of practice.(f) Collaborative agreements and protocols shall be available for inspection and review by the board or its agents at any time during the pharmacist's normal business hours.N.H. Admin. Code § Ph 1105.01
Derived from Volume XXXVIII Number 06, Filed February 8, 2018, Proposed by #12464, Effective 1/23/2018, Expires 1/23/2028.Amended by Number 28, Filed July 13, 2023, Proposed by #13670, Effective 8/20/2023, Expires 8/20/2033.